Mechanistic analysis of macrophage response to IRAK-1 gene knockdown by a smart polymer-antisense oligonucleotide therapeutic

An excessive inflammatory response is a clinical problem following major infections and severe injury that may lead to Sepsis Syndrome and Multiple Organ Failure (MOF), including the Acute Respiratory Distress Syndrome (ARDS). Management of excessive inflammation may be possible through control of key inflammatory pathways such as those mediated by the important interleukin-1 receptor associated kinase-1 (IRAK-1). In the current study, we report the impact on gene expression induced by lipopolysaccharide (LPS) stimulation of THP-1 cells treated with an antisense oligonucleotide (ASODN) against the IRAK-1 gene using cDNA microarrays and quantitative RT-PCR. The therapeutic ASODN was delivered using a pH-sensitive, membrane-interactive polymer that destabilizes the endosomal membrane to enhance access cytoplasmic delivery in targeted cells. Following LPS stimulation, the anti-inflammatory activity of ASODN against the IRAK-1 gene expression is evidenced by the lower expression of inflammatory chemokines, cytokines and acute-phase proteins compared to control cells. These results provide a larger mechanistic picture of IRAK-1 knockdown by this polymer therapeutic in macrophage-like cells.

[1]  L. Bendall.  Chemokines and their receptors in disease. , 2005, Histology and histopathology.

[2]  C. Marsh,et al.  Toward functional proteomics of alveolar macrophages. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[3]  A. Hoffman,et al.  Smart polymeric carriers for enhanced intracellular delivery of therapeutic macromolecules , 2005, Expert opinion on biological therapy.

[4]  M. Matthay,et al.  Pulmonary Edema Fluid from Patients with Early Lung Injury Stimulates Fibroblast Proliferation through IL-1β-Induced IL-6 Expression 1 , 2004, The Journal of Immunology.

[5]  R. Maier,et al.  Modulation of Macrophage Responsiveness to Lipopolysaccharide by IRAK-1 Manipulation , 2004, Shock.

[6]  G. Hunninghake,et al.  Second messenger pathways in pulmonary host defense. , 2003, Annual review of physiology.

[7]  Jean Campbell,et al.  Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Anand Kumar,et al.  Septic shock, multiple organ failure, and acute respiratory distress syndrome , 2003, Current opinion in pulmonary medicine.

[9]  C. F. Bennett,et al.  Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents , 2003, The Journal of Biological Chemistry.

[10]  Jean Campbell,et al.  Bioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugs. , 2003, Bioconjugate chemistry.

[11]  P. Coyle,et al.  Metallothionein: the multipurpose protein , 2002, Cellular and Molecular Life Sciences CMLS.

[12]  D. L. Weeks,et al.  Oligonucleotide-based strategies to reduce gene expression. , 2001, Differentiation; research in biological diversity.

[13]  C. Kooperberg,et al.  Widespread Collaboration of Isw2 and Sin3-Rpd3 Chromatin Remodeling Complexes in Transcriptional Repression , 2001, Molecular and Cellular Biology.

[14]  N. Mackman,et al.  LPS induction of gene expression in human monocytes. , 2001, Cellular signalling.

[15]  Shuguang Wu,et al.  Antisense IRAK-1 oligonucleotide blocks activation of NF-κB and AP-1 induced by IL-18 , 2000 .

[16]  H. Bluethmann,et al.  Metallothionein induction by restraint stress: role of glucocorticoids and IL-6. , 2000, Cytokine.

[17]  C. Dinarello,et al.  The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. , 2000, Immunology today.

[18]  A. Fein,et al.  Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. , 2000, Critical care clinics.

[19]  S. Tóth,et al.  Antisense strategies: functions and applications in immunology. , 1999, Immunology letters.

[20]  S. Wasserman,et al.  Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. , 1999, Journal of immunology.

[21]  Crafford A. Harris,et al.  Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 Production , 1998, The Journal of experimental medicine.

[22]  Douglas K. Miller,et al.  The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation* , 1997, The Journal of Biological Chemistry.

[23]  G. Zimmerman,et al.  The acute respiratory distress syndrome. , 1996, The Journal of clinical investigation.

[24]  D. Goeddel,et al.  NF-κB Activation by Interleukin-1 (IL-1) Requires an IL-1 Receptor-associated Protein Kinase Activity (*) , 1995, The Journal of Biological Chemistry.

[25]  S. De,et al.  Endotoxin induction of murine metallothionein gene expression. , 1990, The Journal of biological chemistry.

[26]  G. Andrews,et al.  Identification of a signal transducer and activator of transcription (STAT) binding site in the mouse metallothionein-I promoter involved in interleukin-6-induced gene expression. , 1999, The Biochemical journal.